MedTrace Logo

A Registry Study of Shujinjianyao Pill Used in Clinical Real World

NCT03598153 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2018-08-02

No results posted yet for this study

Summary

The purpose of this study is to get to know how Shujinjianyao Pill in hospital results in drug-induced liver injury or other adverse drug reactions from a cohort event monitoring as registration research.

Conditions

  • Sciatica

Interventions

DRUG

Shujinjianyao Pill

According to the usage and dosage of the instructions, patients should use the medicine dialectically and rationally for 4 weeks.

Sponsors & Collaborators

  • Wangjing Hospital, China Academy of Chinese Medical Sciences

    collaborator OTHER

  • China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Yanming Xie, BA · Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-25
Primary Completion
2019-10-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03598153 on ClinicalTrials.gov